Skip to main content
. 2022 Mar 4;12:845935. doi: 10.3389/fonc.2022.845935

Table 1.

Clinicopathologic Characteristics of 708 luminal breast cancers with HER2-negativity.

Characteristics Number (%)
Age(years)
 <50 346 (48.9)
 ≥50 362 (51.1)
BMI
 <24 446 (63.0)
 ≥24 262 (37.0)
Menopausal status
 Pre- 362 (51.1)
 Post- 327 (46.2)
 Unknown 19 (2.7)
Tumor size
 <2cm 449 (63.4)
 ≥2cm 259 (36.6)
Lymph node metastasis
 Negative 607 (85.7)
 Positive 101 (14.3)
TNM grade
 I 422 (59.6)
 II 224 (31.6)
 III 62 (8.8)
Histology type
 Infiltrating ductal carcinoma 635 (89.7)
 Infiltrating lobular carcinoma 15 (2.1)
 Others 57 (8.1)
Luminal subtype
 Luminal A 316 (44.6)
 Luminal B 392 (55.4)
Operation type
 Modified radical mastectomy 375 (53.0)
 Breast-conserving surgery 249 (35.2)
 Mammectomy 72 (10.2)
 Others 12 (1.7)
Chemotherapy
 Neoadjuvant chemotherapy 66 (9.3)
 Adjuvant chemotherapy 362 (51.1)
 No chemotherapy 280 (39.5)
Radiotherapy
 No 310 (43.8)
 Yes 398 (56.2)
Characteristics Number (%)
Age (years)
 <50 346 (48.9)
 ≥50 362 (51.1)
BMI
 <24 446 (63.0)
 ≥24 262 (37.0)
Menopausal status
 Pre- 362 (51.1)
 Post- 327 (46.2)
 Unknown 19 (2.7)
Tumor size
 <2cm 449 (63.4)
 ≥2cm 259 (36.6)
Lymph node metastasis
 Negative 607 (85.7)
 Positive 101 (14.3)
TNM grade
 I 422 (59.6)
 II 224 (31.6)
 III 62 (8.8)
Histology type
 Infiltrating ductal carcinoma 635 (89.7)
 Infiltrating lobular carcinoma 15 (2.1)
 Others 57 (8.1)
Luminal subtype
 Luminal A 316 (44.6)
 Luminal B 392 (55.4)
Operation type
 Modified radical mastectomy 375 (53.0)
 Breast-conserving surgery 249 (35.2)
 Mammectomy 72 (10.2)
 Others 12 (1.7)
Chemotherapy
 Neoadjuvant chemotherapy 66 (9.3)
 Adjuvant chemotherapy 362 (51.1)
 No chemotherapy 280 (39.5)
Radiotherapy
 No 310 (43.8)
 Yes 398 (56.2)